Actually, the overactivation of FOXO1 in ALS muscle could explain the switch from glucose to muscle lipid utilisation described at early stages in the SOD1-G93A mouse, prior to symptoms onset and MN loss [12, 51]. Here, SOD1 is linked to amyotrophic lateral sclerosis.